talazoparib,enzalutamide
pfizer,astellas
['prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'talazo', 'enzalu', 'talapro-2', 'enzalutamide']
talapro-2: talazoparib plus enzalutamide resulted in a statistically and clinical significant improvement in rpfs by bicr over placebo plus enzalutamide across the all-comers population in the first-line mcrpc setting. be careful with toxicities.#prostatecancer #gu23 
Jefe de Servicio de Oncología Médica. Hospital Universitario Lucus Augusti, HULA. Grupo de Investigación Oncológica Traslacional, GIOT HULA. Cuenta personal